Sarah Iribarren

Sarah Iribarren

Auto-generated profile, based on publicly available information

Sarah Iribarren

University of Washington

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SISarah J Iribarren
Sarah J Iribarren
KCKenrick Cato
Kenrick Cato
LFLouise Falzon
Louise Falzon
PSPatricia W Stone
Patricia W Stone
Mobile health (mHealth) is often reputed to be cost-effective or cost-saving. Despite optimism, the strength of the evidence supporting this assertion has been limited. In this systematic review the body of evidence related to economic evaluations of mHealth interventions is assessed and summarized. Seven electronic bibliographic databases, grey literature, and relevant references were searched. Eligibility criteria included original articles, comparison of costs and consequences of interventions (one categorized as a primary mHealth intervention or mHealth intervention as a component of other interventions), health and economic outcomes and published in English. Full economic evaluations were appraised using the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist and The PRISMA guidelines were followed. Searches identified 5902 results, of which 318 were examined at full text, and 39 were included in this review. The 39 studies spanned 19 countries, most of which were conducted in upper and upper-middle income countries (34, 87.2%). Primary mHealth interventions (35, 89.7%), behavior change communication type interventions (e.g., improve attendance rates, medication adherence) (27, 69.2%), and short messaging system (SMS) as the mHealth function (e.g., used to send reminders, information, provide support, conduct surveys or collect data) (22, 56.4%) were most frequent; the most frequent disease or condition focuses were outpatient clinic attendance, cardiovascular disease, and diabetes. The average percent of CHEERS checklist items reported was 79.6% (range 47.62–100, STD 14.18) and the top quartile reported 91.3–100%. In 29 studies (74.3%), researchers reported that the mHealth intervention was cost-effective, economically beneficial, or cost saving at base case. Findings highlight a growing body of economic evidence for mHealth interventions. Although all studies included a comparison of intervention effectiveness of a health-related outcome and reported economic data, many did not report all recommended economic outcome items and were lacking in comprehensive analysis. The identified economic evaluations varied by disease or condition focus, economic outcome measurements, perspectives, and were distributed unevenly geographically, limiting formal meta-analysis. Further research is needed in low and low-middle income countries and to understand the impact of different mHealth types. Following established economic reporting guidelines will improve this body of research.

14 June 2016 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
RCRuth Marie Masterson Creber
Ruth Marie Masterson Creber
MMMathew S. Maurer
Mathew S. Maurer
MRMeghan Reading
Meghan Reading
GHGrenny Hiraldo
Grenny Hiraldo
KHKathleen T. Hickey
Kathleen T. Hickey
SISarah Iribarren
Sarah Iribarren
Mobile and tablet apps, ubiquitous and pervasive computing, wearable computing and domotics for health.

11 January 2021 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
SISarah J Iribarren
Sarah J Iribarren
TATokunbo O Akande
Tokunbo O Akande
KKKendra Kamp
Kendra Kamp
DBDwight Barry
Dwight Barry
YKYazan G Kader
Yazan G Kader
ESElizabeth Suelzer
Elizabeth Suelzer
Background: Interventions aimed at modifying behavior for promoting health and disease management are traditionally resource intensive and difficult to scale. Mobile health apps are being used for these purposes; however, their effects on health outcomes have been mixed. Objective: This study aims to summarize the evidence of rigorously evaluated health-related apps on health outcomes and explore the effects of features present in studies that reported a statistically significant difference in health outcomes. Methods: A literature search was conducted in 7 databases (MEDLINE, Scopus, PsycINFO, CINAHL, Global Index Medicus, Cochrane Central Register of Controlled Trials, and Cochrane Database of Systematic Reviews). A total of 5 reviewers independently screened and extracted the study characteristics. We used a random-effects model to calculate the pooled effect size estimates for meta-analysis. Sensitivity analysis was conducted based on follow-up time, stand-alone app interventions, level of personalization, and pilot studies. Logistic regression was used to examine the structure of app features. Results: From the database searches, 8230 records were initially identified. Of these, 172 met the inclusion criteria. Studies were predominantly conducted in high-income countries (164/172, 94.3%). The majority had follow-up periods of 6 months or less (143/172, 83.1%). Over half of the interventions were delivered by a stand-alone app (106/172, 61.6%). Static/one-size-fits-all (97/172, 56.4%) was the most common level of personalization. Intervention frequency was daily or more frequent for the majority of the studies (123/172, 71.5%). A total of 156 studies involving 21,422 participants reported continuous health outcome data. The use of an app to modify behavior (either as a stand-alone or as part of a larger intervention) confers a slight/weak advantage over standard care in health interventions (standardized mean difference=0.38 [95% CI 0.31-0.45]; I2=80%), although heterogeneity was high. Conclusions: The evidence in the literature demonstrates a steady increase in the rigorous evaluation of apps aimed at modifying behavior to promote health and manage disease. Although the literature is growing, the evidence that apps can improve health outcomes is weak. This finding may reflect the need for improved methodological and evaluative approaches to the development and assessment of health care improvement apps. Trial Registration: PROSPERO International Prospective Register of Systematic Reviews CRD42018106868; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=106868

18 September 2015 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
RSRebecca Schnall
Rebecca Schnall
JMJocelyn Patterson Mosley
Jocelyn Patterson Mosley
SISarah J Iribarren
Sarah J Iribarren
SBSuzanne Bakken
Suzanne Bakken
ACAlex Carballo-Diéguez
Alex Carballo-Diéguez
WIWilliam Brown Iii
William Brown Iii
Mobile and tablet apps, ubiquitous and pervasive computing, wearable computing and domotics for health.

13 May 2016 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
SISarah J Iribarren
Sarah J Iribarren
RSRebecca Schnall
Rebecca Schnall
PSPatricia W Stone
Patricia W Stone
ACAlex Carballo-Diéguez
Alex Carballo-Diéguez
Mobile and tablet apps, ubiquitous and pervasive computing, wearable computing and domotics for health.

29 November 2012 in Journal of Research in Nursing
Verified
Journal Article
Open access
PDF file
JGJulieta Galante
Julieta Galante
SISarah J. Iribarren
Sarah J. Iribarren
PPPatricia F. Pearce
Patricia F. Pearce
Objective: Mindfulness-based cognitive therapy (MBCT) is a programme developed to prevent depression relapse, but has been applied for other disorders. Our objective was to systematically review and meta-analyse the evidence on the effectiveness and safety of MBCT for the treatment of mental disorders. Methods: Searches were completed in CENTRAL, MEDLINE, EMBASE, LILACS, PsychINFO, and PsycEXTRA in March 2011 using a search strategy with the terms ‘mindfulness-based cognitive therapy’, ‘mindfulness’, and ‘randomised controlled trials’ without time restrictions. Selection criteria of having a randomised controlled trial design, including patients diagnosed with mental disorders, using MBCT according to the authors who developed MBCT and providing outcomes that included changes in mental health were used to assess 608 reports. Two reviewers applied the pre-determined selection criteria and extracted the data into structured tables. Meta-analyses and sensitivity analyses were completed. Results: Eleven studies were included. Most of them evaluated depression and compared additive MBCT against usual treatment. After 1 year of follow-up MBCT reduced the rate of relapse in patients with three or more previous episodes of depression by 40% (5 studies, relative risk [95% confidence interval]: 0.61 [0.48, 0.79]). Other meta-analysed outcomes were depression and anxiety, both with significant results but unstable in sensitivity analyses. Methodological quality of the reports was moderate. Conclusion: Based on this review and meta-analyses, MBCT is an effective intervention for patients with three or more previous episodes of major depression.